Wedbush Securities’s DermTech, Inc. Common Stock DMTK Stock Holding History

Wedbush Securities’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,040	Closed	-$40K	–	1113
2022 Q3	$40K	Sell	10,040 -500	-5%	-$3.08K	﹤0.01%	1016
2022 Q2	$58K	Buy	+10,540	New	+$86.3K	﹤0.01%	1027
2022 Q1	–	Sell	-10,079	Closed	-$159K	–	1223
2021 Q4	$159K	Sell	10,079 -5,410	-35%	-$130K	0.01%	1085
2021 Q3	$497K	Buy	15,489 +4,994	+48%	+$175K	0.02%	617
2021 Q2	$436K	Buy	+10,495	New	+$431K	0.02%	682

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wedbush Securities's DMTK Position: Q4 2022 in Review

Wedbush Securities sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2022, closing a stake of 10,040 shares — an estimated $40K sold.

Wedbush Securities first reported a position in DMTK in Q2 2021 and held it in 5 quarters. The position peaked at $497K in Q3 2021. 94 funds tracked by Wall St. Rank hold DMTK as of Q4 2022.

Wedbush Securities reported no remaining DermTech, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Wedbush Securities sold 10,040 DermTech, Inc. Common Stock shares in Q4 2022, an estimated $40K.
Wedbush Securities first reported a position in DermTech, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
Wedbush Securities's DermTech, Inc. Common Stock position peaked at $497K in Q3 2021.
94 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2022.

Based on Wedbush Securities's 13F filing for Q4 2022, filed 31 Jan 2023.